GEORGIA: The prevalence and risk factors for new-onset interstitial lung disease (ILD) among previously ILD-negative systemic sclerosis patients are reported in new research presented at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting. Interstitial lung disease (ILD) is a major consequence and cause of death in people…Read More
Study discovers risk factors for newonset interstitial lung disease in systemic sclerosis
